[HTML][HTML] Treatment of coronavirus disease 2019 (COVID-19) patients with convalescent plasma
…, RJ Olsen, C Leveque, MR Schwartz, M Dey… - The American journal of …, 2020 - Elsevier
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2, has spread globally, and no proven treatments are available. Convalescent plasma …
coronavirus 2, has spread globally, and no proven treatments are available. Convalescent plasma …
Temporal feature-based classification into myocardial infarction and other cvds merging cnn and bi-lstm from ecg signal
… (Monisha Dey and Nuzaer Omar contributed equally to this work.) (Corresponding author:
Monisha Dey.) The authors are with the Department of Electrical and Electronic Engineering, …
Monisha Dey.) The authors are with the Department of Electrical and Electronic Engineering, …
Challenges with Developing In Vitro Dissolution Tests for Orally Inhaled Products (OIPs)
…, J Arp, A Casazza, A Colombani, A Cooper, M Dey… - Aaps Pharmscitech, 2012 - Springer
The purpose of this article is to review the suitability of the analytical and statistical techniques
that have thus far been developed to assess the dissolution behavior of particles in the …
that have thus far been developed to assess the dissolution behavior of particles in the …
Treatment of COVID-19 patients with convalescent plasma in Houston, Texas
Background COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has spread globally, and no proven treatments are available. Convalescent …
(SARS-CoV-2), has spread globally, and no proven treatments are available. Convalescent …
A comparative study of support vector machine and Naive Bayes classifier for sentiment analysis on Amazon product reviews
This paper represents a comparison between two machine learning approaches for analyzing
the sentiment of the customers' reviews on Amazon products. Eventually, reviews of a …
the sentiment of the customers' reviews on Amazon products. Eventually, reviews of a …
Detection of myocardial infarction from ECG signal through combining CNN and Bi-LSTM
Myocardia infarction (MI) otherwise known as heart attack, is one of the prime causes of
death of individuals worldwide. The electrocardiogram (ECG) signal is clinically used by …
death of individuals worldwide. The electrocardiogram (ECG) signal is clinically used by …
Real time driver fatigue detection based on facial behaviour along with machine learning approaches
S Dey, SA Chowdhury, S Sultana… - 2019 IEEE …, 2019 - ieeexplore.ieee.org
This paper is concerned about the detection procedure of drowsiness that causes fatal road
accidents leading to death. Increasing lack of awareness of traffic rules is doubling the …
accidents leading to death. Increasing lack of awareness of traffic rules is doubling the …
Discovery and control of succinimide formation and accumulation at aspartic acid residues in the complementarity-determining region of a therapeutic monoclonal …
ZL VanAernum, JA Sergi, M Dey, T Toner… - Pharmaceutical …, 2023 - Springer
Purpose Succinimide formation and isomerization alter the chemical and physical
properties of aspartic acid residues in a protein. Modification of aspartic acid residues within …
properties of aspartic acid residues in a protein. Modification of aspartic acid residues within …
A two one-sided parametric tolerance interval test for control of delivered dose uniformity. Part 1—characterization of FDA proposed test
S Novick, D Christopher, M Dey, S Lyapustina… - Aaps Pharmscitech, 2009 - Springer
The FDA proposed a parametric tolerance interval (PTI) test at the October 2005 Advisory
Committee meeting as a replacement of the attribute (counting) test for delivered dose …
Committee meeting as a replacement of the attribute (counting) test for delivered dose …
A two one-sided parametric tolerance interval test for control of delivered dose uniformity—part 2—Effect of changing parameters
S Novick, D Christopher, M Dey, S Lyapustina… - AAPS …, 2009 - Springer
This article examines the effects of changing parameters in the test which was proposed by
the FDA at the October 2005 Advisory Committee meeting for confirming delivered dose …
the FDA at the October 2005 Advisory Committee meeting for confirming delivered dose …